Compounds > sb 203580
Page last updated: 2024-09-05

sb 203580 and tg101209

sb 203580 has been researched along with tg101209 in 2 studies

Compound Research Comparison

Studies
(sb 203580)		Trials
(sb 203580)		Recent Studies (post-2010)
(sb 203580)		Studies
(tg101209)		Trials
(tg101209)		Recent Studies (post-2010) (tg101209)
3,48941,13736031

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)tg101209 (IC50)
Tyrosine-protein kinase JAK2Homo sapiens (human)0.006
Bromodomain-containing protein 4Homo sapiens (human)0.13
Serine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)3.5
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.025
Bromodomain testis-specific proteinHomo sapiens (human)0.23

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1
Munoz, L1

Reviews

1 review(s) available for sb 203580 and tg101209

ArticleYear
Non-kinase targets of protein kinase inhibitors.
    Nature reviews. Drug discovery, 2017, Volume: 16, Issue:6

    Topics: Animals; Drug Design; Drug Evaluation, Preclinical; Humans; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein Kinases

2017

Other Studies

1 other study(ies) available for sb 203580 and tg101209

ArticleYear
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011